CHWY vs HALO · P/E 45, rev $12.60B vs P/E 15, rev $857.7M
Chewy Inc (CHWY) versus Halozyme Therapeutics Inc (HALO) — a side-by-side from cached financials, not a winner call.
Chewy Inc (CHWY) is a internet retail company listed on US.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Latest reported CHWY revenue for 2026-02-01 was $12.60B. Net income was $222.8M. Revenue was up 6.2% from 2025-02-02 to 2026-02-01. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
CHWY currently screens at market cap $16.92B and trailing P/E 45.0. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Not investment advice. Open the CHWY and HALO stock pages for the full models.
Not investment advice.